Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monocyte”

513 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 513 results

Not applicableUnknownNCT00162838
What this trial is testing

Effects of Periodontal Pathogens, Porphyromonas Gingivalis and Tannerella Forsythensis, on Cytokine Production From Human Monocyte-Derived Dendritic Cells

Who this might be right for
Periodontal Disease
National Taiwan University Hospital 20
Not applicableStudy completedNCT03431532
What this trial is testing

Monocyte Subsets Altered by Anesthesia

Who this might be right for
Regional AnesthesiaGeneral AnesthesiaImmune Function
University Hospital, Saarland 20
Not applicableStudy completedNCT07064278
What this trial is testing

Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children

Who this might be right for
Refractory Mycoplasma Pneumoniae Pneumonia
Children's Hospital of Hebei Province 260
Early research (Phase 1)Looking for participantsNCT06429449
What this trial is testing

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyeloid LeukemiaMonocytic Leukemia
University of Colorado, Denver 30
Not applicableLooking for participantsNCT06007404
What this trial is testing

Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents

Who this might be right for
Type 2 DiabetesInsulin ResistanceObesity+2 more
University of Michigan 175
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00070135
What this trial is testing

Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Alliance for Clinical Trials in Oncology 121
Not applicableActive Not RecruitingNCT05470218
What this trial is testing

Leucine, MTOR and Athero

Who this might be right for
Atherosclerosis
University of Missouri-Columbia 10
Testing effectiveness (Phase 2)Study completedNCT00048347
What this trial is testing

Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT00027872
What this trial is testing

Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+18 more
National Cancer Institute (NCI) 125
Not applicableLooking for participantsNCT06957145
What this trial is testing

Vista Protein Expression of Monocyte and T Cell Subsets in Multiple Sclerosis and Its Clinical Correlation

Who this might be right for
Multiple Sclerosis, MS
Koç University 60
Testing effectiveness (Phase 2)Study completedNCT04055844
What this trial is testing

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyeloid and Monocytic LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)Ended earlyNCT00818649
What this trial is testing

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 16
Not applicableUnknownNCT03000738
What this trial is testing

The Value and Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of Lymphomas

Who this might be right for
Lymphoma,Non-HodgkinDiffuse Large B Cell LymphomaPeripheral T-Cell Lymphoma
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Early research (Phase 1)Study completedNCT02433509
What this trial is testing

Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
China Medical University Hospital 6
Testing effectiveness (Phase 2)Ended earlyNCT00814164
What this trial is testing

Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT04184232
What this trial is testing

Treatment of Recurrent Bladder Cancer With Dendritic Cells

Who this might be right for
Bladder Cancer
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 17
Testing effectiveness (Phase 2)Looking for participantsNCT03670966
What this trial is testing

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia in Remission+9 more
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01168219
What this trial is testing

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAdult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic Leukemia+17 more
National Cancer Institute (NCI) 68
Load More Results